Phrixus Pharmaceuticals Inc — Form D
Phrixus Pharmaceuticals Inc of Ann Arbor, MI, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-08. The offering totals $1.0M, of which $100K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-08
- Form: D
- Accession: 0001408693-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $100K
- Remaining: $900K
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2013-09-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-204200
Issuer
- Name: Phrixus Pharmaceuticals Inc
- CIK: 0001408693
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1600 HURON PARKWAY, Ann Arbor, MI, 48109
- Phone: 734-358-9015
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gerald A Brennan | Director | Ann Arbor, MI |
| Leslie A Browne | Director | Ann Arbor, MI |
| Thomas A Collet | Director | Ann Arbor, MI |
| Bruce A Markham | Director | Ann Arbor, MI |
| Thomas A Collet | Executive Officer | Ann Arbor, MI |
More